Search results for "Rippling"

showing 5 items of 5 documents

Wavelength selection of rippling patterns in myxobacteria

2016

Rippling patterns of myxobacteria appear in starving colonies before they aggregate to form fruiting bodies. These periodic traveling cell density waves arise from the coordination of individual cell reversals, resulting from an internal clock regulating them, and from contact signaling during bacterial collisions. Here we revisit a mathematical model of rippling in myxobacteria due to Igoshin et al.\ [Proc. Natl. Acad. Sci. USA {\bf 98}, 14913 (2001) and Phys. Rev. E {\bf 70}, 041911 (2004)]. Bacteria in this model are phase oscillators with an extra internal phase through which they are coupled to a mean-field of oppositely moving bacteria. Previously, patterns for this model were obtaine…

0301 basic medicinePeriodicityPhase transitionPhase (waves)FOS: Physical sciencesModels BiologicalMotion03 medical and health sciencesQuantum mechanicsWavenumberComputer SimulationMyxococcalesPhysics - Biological PhysicsCondensed Matter - Statistical MechanicsPhysicsStatistical Mechanics (cond-mat.stat-mech)Kuramoto modelNonlinear systemWavelength030104 developmental biologyClassical mechanicsNonlinear DynamicsMean field theoryBiological Physics (physics.bio-ph)RipplingLinear Models
researchProduct

Immunosuppressive treatment of rippling muscles in patients with myasthenia gravis

2000

Rippling muscle disease is a rare autosomal dominant disorder that may occur sporadically. In this report two patients presenting with rippling muscles followed by myasthenia gravis are described. Our first patient developed rippling muscles about 1 month after infection with Yersinia enterocolitica. Two years later myasthenia gravis appeared. Our second patient had a 2-year history of asthma prior to the onset of rippling muscles which preceded the myasthenic symptoms by 4-8 weeks. Acetylcholine receptor and anti-skeletal muscle antibody titers were positive in both patients. In both patients the rippling phenomena worsened with pyridostigmine treatment but markedly improved after immunosu…

AdultMalemedicine.medical_specialtymedicine.medical_treatmentAzathioprineGastroenterologyMuscular DiseasesPhysical StimulationInternal medicineAzathioprineMyasthenia GravismedicineHumansGenetics (clinical)AsthmaAcetylcholine receptorbusiness.industryImmunosuppressionMiddle Agedmedicine.diseaseMyasthenia gravisNeurologyPyridostigmineRipplingPediatrics Perinatology and Child HealthImmunologyNeurology (clinical)medicine.symptombusinessImmunosuppressive AgentsMuscle ContractionPyridostigmine BromideMuscle contractionmedicine.drugNeuromuscular Disorders
researchProduct

Rippling of two-dimensional materials by line defects

2020

Two-dimensional materials and their mechanical properties are known to be profoundly affected by rippling deformations. However, although ripples are fairly well understood, less is known about their origin and controlled modification. Here, motivated by recent reports of laser-controlled creation of line defects in graphene, we investigate how line defects could be used to control rippling in graphene and other two-dimensional materials. By sequential multi-scale coupling of density-functional tight-binding and continuum elasticity simulations, we quantify the amount of rippling when the number and the cumulative length of the line defects increase. Simulations show that elastic sheets wit…

Materials sciencemechanical deformationelastic modulus02 engineering and technology01 natural scienceslaw.inventionlaw0103 physical sciencesgrafeeniElasticity (economics)materiaalitiede010306 general physicsSofteningCondensed Matter - Mesoscale and Nanoscale PhysicsCondensed matter physicsline defectsGraphenebending021001 nanoscience & nanotechnologykimmoisuusfysikaaliset ominaisuudetLine defectsNonlinear systemMultiscale couplingRipplingkiinteän olomuodon fysiikka0210 nano-technologyPhysical Review B
researchProduct

Limits of lateral expansion in two-dimensional materials with line defects

2021

The flexibility of two-dimensional (2D) materials enables static and dynamic ripples that are known to cause lateral contraction, shrinking of the material boundary. However, the limits of 2D materials' \emph{lateral expansion} are unknown. Therefore, here we discuss the limits of intrinsic lateral expansion of 2D materials that are modified by compressive line defects. Using thin sheet elasticity theory and sequential multiscale modeling, we find that the lateral expansion is inevitably limited by the onset of rippling. The maximum lateral expansion $\chi_{max}\approx 2.1\cdot t^2\sigma_d$, governed by the elastic thickness $t$ and the defect density $\sigma_d$, remains typically well belo…

PhysicsCondensed Matter - Mesoscale and Nanoscale PhysicsPhysics and Astronomy (miscellaneous)Condensed matter physicsBoundary (topology)SigmaFOS: Physical sciencesApproxLateral expansionMultiscale modelingkimmoisuusStrain engineeringRipplingMesoscale and Nanoscale Physics (cond-mat.mes-hall)grafeeniGeneral Materials SciencesimulointiohutkalvotContraction (operator theory)
researchProduct

Immune-mediated rippling muscle disease with myasthenia gravis: a report of seven patients with long-term follow-up in two.

2009

We report seven patients with immune-mediated rippling muscle disease (iRMD) and AChR-antibody positive myasthenia gravis (MG) without germline caveolin-3 gene mutations. We describe the follow-up of two patients and the clinical features of five new patients (1 female, 4 male, aged 32 to 69 years). These presented with significant generalized, exercise-induced and electrically-silent muscle rippling with myalgia, combined with generalized MG. In two of the seven patients, MG appeared before iRMD. Mediastinal imaging excluded thymic alterations in all, although two had other coincident tumours. Myalgia and rippling were aggravated by acetylcholinesterase-inhibitor treatment. Generalized MG …

myalgiaAdultMalePathologymedicine.medical_specialtyCaveolin 3Immunogenicmedicine.medical_treatmentMuscle Fibers SkeletalMuscle ProteinsCaveolin-3; Immunogenic; Myasthenia gravis; Rippling muscle disease; TherapyAzathioprineThymus GlandGene mutationBiologyCaveolaeDysferlinCaveolin-3Muscular DiseasesAzathioprineMyasthenia GravismedicineHumansMuscle SkeletalGenetics (clinical)AgedAutoantibodiesSarcolemmaElectromyographyAutoantibodyRippling muscle diseasePlasmapheresisMiddle Agedmedicine.diseaseMyasthenia gravisNeurologyPediatrics Perinatology and Child Healthbiology.proteinPlasmapheresisFemaleSteroidsTherapyNeurology (clinical)Cholinesterase Inhibitorsmedicine.symptommedicine.drugFollow-Up StudiesMuscle ContractionNeuromuscular disorders : NMD
researchProduct